Results

Total Results: 1,027 records

Showing results for "drugs".

341. Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q4J7tsThw_6nwfB-p-f5Hp
     March 01, 2009 - for GI bleeding increases with age and that the men are not taking nonsteroidal anti- inflammatory drugs … Figure 2 were developed assum- ing that the men are not currently taking nonsteroidal anti- inflammatory drugs … for GI bleeding increases with age and that the women are not taking nonsteroidal anti-inflammatory drugs … Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP

342. C97Uqjxbuhjnuondkvchzu (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/c97uqjXbUHjNuoNDkvChZu
     August 01, 2013 - screen- ing for and interventions to decrease the unhealthy use of other substances, including illicit drugs … J Stud Alcohol Drugs. 2008;69:535-8. [PMID: 18612569] 19. … J Stud Alcohol Drugs. 2010;71:23-31. [PMID: 20105410] 22. Grossberg PM, Brown DD, Fleming MF. … J Stud Alcohol Drugs Suppl. 2009:131-41. [PMID: 19538921] 24.

343. Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/CXDusYW7s2xdypXMpnW9sw
     June 20, 2023 - benzodiazepines are com- bined with other medicines, such as opioid pain relievers, alcohol, or illicit drugs … Accessed August 31, 2021. https://www.fda.gov/drugs/drug-safety- and-availability/fda-requiring-boxed-warning … Accessed August 31, 2021. https://www.fda.gov/drugs/drug-safety-and- availability/fda-drug-safety-communication-fda

344. Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R33bUm6oyjhWnbw96pJHwE
     April 01, 2009 - When data are pooled for individual drugs, they have not yielded statistically significant increases … Suicidality in pediatric patients treated with antidepressant drugs. … Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are … CNS Drugs. 2004;18(15):1119–1132 76. Søndergård L, Kvist K, Andersen PK, Kessing LV. … ; International Federation of Pharmaceutical Manufacturers and Associations Clinical Trials Portal; Drugs

345. Final Evidence Review: Glaucoma: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review38/glaucoma-screening
     February 15, 2013 - examined treatments currently used for OAG, including medical, laser, and incisional surgery and excluded drugs … Both drugs increased iris pigmentation. … Jampel: Consultancy : Ivantis, Transcend, Endo Optics, Allergan, Aerie Pharmaceuticals, Intersect ENT … Studies that used the following drugs were excluded: epinephrine, dipivefrin, apraclonidine, pilocarpine … Comparisons of case series, patient education reports, laboratory or autopsy data, letter or commentaries, drugs

346. Archived: Final Evidence Review: Glaucoma: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review38/glaucoma-screening-2013
     February 15, 2013 - examined treatments currently used for OAG, including medical, laser, and incisional surgery and excluded drugs … Both drugs increased iris pigmentation. … Jampel: Consultancy : Ivantis, Transcend, Endo Optics, Allergan, Aerie Pharmaceuticals, Intersect ENT … Studies that used the following drugs were excluded: epinephrine, dipivefrin, apraclonidine, pilocarpine … Comparisons of case series, patient education reports, laboratory or autopsy data, letter or commentaries, drugs

347. Current Processes: Refining Evidence-based Recommendation Development - Table 1 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/current-processes-refining-evidence-based-recommendation-development-table-1
     June 01, 2007 - Current Processes: Refining Evidence-based Recommendation Development - Table 1 Procedures for Developing a Recommendation Statement a Activity b Responsible Parties Timeline Topic selection Topic Prioritization Workgroup, a subset of Task Force members and AHRQ and EPC staff The Workgroup meets periodically thr…

348. Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kQWppPe7wLrdrHnbqM2BQu
     December 05, 2017 - Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women Population Postmenopausal women Postmenopausal women who have had a hysterectomy Recommendat…

349. Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qpv8h6ZMbYLYzakVrNQoj2
     October 11, 2022 - but 9 were conducted exclusively in adolescents Pharmacotherapy studies were limited to first-line drugs … but 5 were conducted exclusively in adolescents Pharmacotherapy studies were limited to first-line drugs … Fourth, the review was limited to first-line drugs approved for pediatric use by the FDA. … Accessed February 15, 2021. https://www.fda.gov/ drugs/postmarket-drug-safety-information- patients-and-providers … Suicidality in pediatric patients treated with antidepressant drugs.

350. Our Partners | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/our-partners
     May 01, 2022 - Our Partners Share to Facebook Share to X Share to WhatsApp Share to Email Print As part of its efforts to make its work as transparent as possible and enhance the accuracy and relevance of its recommendations, the Task Force works with a gro…

351. Screening for Dyslipidemia in Younger Adults: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SaASReVeD_fpHZQbeBZD5s
     October 01, 2016 - Screening for Dyslipidemia in Younger Adults: A Systematic Review Screening for Dyslipidemia in Younger Adults: A Systematic Review for the U.S. Preventive Services Task Force Roger Chou, MD; Tracy Dana, MLS; Ian Blazina, MPH; Monica Daeges, BA; Christina Bougatsos, MPH; and Thomas L. Jeanne, MD, MPH Background: Dys…

352. Screening for Depression in Adults: USPSTF Final Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/BnHj53HwgSBNXMvnyavxfS
     January 26, 2016 - Clinical review: relationship between antidepressant drugs and suicidality in adults. … Memorandum: Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). … CNS Drugs. 2006;20(2):143-151. 28. McDonagh MS, Matthews A, Phillipi C, et al.

353. Archived: Depression in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-children-and-adolescents-screening-2009
     March 15, 2009 - Pooled data for individual drugs did not show statistically significant increases in suicide-related

354. Recommendation: Depression and Suicide Risk in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-children-adolescents
     October 11, 2022 - https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medications

355. Recommendation: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/sexually-transmitted-infections-behavioral-counseling
     August 18, 2020 - minorities, persons living with HIV, persons with injection drug use, persons who exchange sex for money or drugs … testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs … , have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic

356. U.S. Preventive Services Task Force Highlights High-Priority Evidence Gaps in 2020 Report to Congresss (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/10th-annual-report-to-congress-bulletin.pdf
     December 03, 2020 - U.S. Preventive Services Task Force Highlights High-Priority Evidence Gaps in 2020 Report to Congresss www.uspreventiveservicestaskforce.org U.S. Preventive Services Task Force Highlights High-Priority Evidence Gaps in 2020 Report to Congress Task Force calls for more research on child and adolescent health …

357. Final Research Plan: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication
     May 27, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions May 27, 2021 Recommendations made by the USPSTF are independent of t…

358. Archived: Obesity in Adults: Screening and Counseling, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-screening-and-counseling-2003
     November 03, 2003 - There are no data on the long-term (longer than 2 years) benefits or adverse effects of these drugs. … Data for sibutramine and orlistat suggest that these drugs have modest but potentially sustained effects

359. Archived: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2012
     October 15, 2012 - Pfizer Pharmaceuticals. Premarin Package Insert. New York: Pfizer Pharmaceuticals, Inc.; 2011.

360. Final Evidence Summary: Tobacco Use in Children and Adolescents: Primary Care Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/other-supporting-document19468/tobacco-and-nicotine-use-prevention-in-children-and-adolescents-primary-care-interventions
     April 28, 2020 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Evidence Summary Tobacco Use in Children and Adolescents: Primary Care Interventions April 28, 2020 Recommendations made by the USPSTF are independent of the U.S. gover…